CancerCare of Maine at Eastern Maine Medical Center
Bangor, Maine, United States
Cancer treatment center in Brewer, Maine
33 Whiting Hill Rd #34, Brewer, ME 04412
About CancerCare of Maine at Eastern Maine Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at CancerCare of Maine at Eastern Maine Medical Center
During the past decade, CancerCare of Maine at Eastern Maine Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 25 clinical trials were completed, i.e. on
average, 416.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
2004-08-01
2009-05-01
Completed
100
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
2008-09-03
2016-02-25
Completed
723
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2010-01-01
2015-12-01
Completed
1,069
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2009-09-01
2016-01-01
Completed
347
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
2009-09-30
2017-11-02
Completed
1,199
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
2011-01-13
2016-11-30
Completed
343
Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer
2012-11-23
2019-02-12
Completed
156
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
2013-02-22
2023-08-26
Active, not recruiting
666
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CancerCare of Maine at Eastern Maine Medical Center" #1 sponsor was "Children's Oncology Group" with 24 trials, followed by "Alliance for Clinical Trials in Oncology" with 23 trials
sponsored, "NSABP Foundation Inc" with 5 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored and "Alliance Foundation Trials, LLC."
with 4 trials sponsored. Other sponsors include 9 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CancerCare of Maine at Eastern Maine Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 60 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 24 different institutions and companies that were
collaborators in the rest 30 trials.
Clinical Trials Conditions at CancerCare of Maine at Eastern Maine Medical Center
According to Clinical.Site data, the most researched conditions in "CancerCare of Maine at Eastern Maine Medical Center" are
"Leukemia" (16 trials), "Breast Cancer" (10 trials), "Lymphoma" (8 trials), "Lung Cancer" (6 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "CancerCare of Maine at Eastern Maine Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at CancerCare of Maine at Eastern Maine Medical Center
Most popular intervention types in "CancerCare of Maine at Eastern Maine Medical Center" are "Drug" (51 trials), "Biological" (25 trials), "Other" (16 trials), "Radiation" (16 trials) and "Procedure" (13 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (14 trials), "etoposide" (13 trials), "filgrastim" (11 trials), "radiation therapy" (10 trials) and "carboplatin" (8 trials). Other intervention names were less common.
Clinical Trials Genders at CancerCare of Maine at Eastern Maine Medical Center
The vast majority of trials in "CancerCare of Maine at Eastern Maine Medical Center" are
63 trials for "All" genders and 10 trials for "Female" genders.
Clinical Trials Status at CancerCare of Maine at Eastern Maine Medical Center
Currently, there are NaN active trials in "CancerCare of Maine at Eastern Maine Medical Center".
undefined are not yet recruiting,
1 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 53 completed trials in CancerCare of Maine at Eastern Maine Medical Center,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in CancerCare of Maine at Eastern Maine Medical Center, 3 "Phase 1"
clinical trials were conducted, 25 "Phase 2" clinical
trials and 29 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 7 trials that are defined as “Not Applicable".